Metraipolis › archive › dc_52ec450c2ebf

Patient Survival and Its Relation to Tumor Absorbed Dose in [177Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors — Europe PMC PMID:42562609

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42562609
DOI
10.2967/jnumed.125.271439
License (as archived)
solo-consultazione
Archived
2026-10-07T17:04:08.163Z
SHA-256 of the archived text
0257bedca70725e2813d37ec0834126e92b78ad0feaa6f42bbad8d21c6b197d2
Stable URL of this page
https://metraipolis.com/documento/dc_52ec450c2ebf

How to cite

Patient Survival and Its Relation to Tumor Absorbed Dose in [177Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors — Europe PMC PMID:42562609 — Europe PMC (en), https://europepmc.org/article/MED/42562609 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_52ec450c2ebf (Metraipolis archive dc_52ec450c2ebf, sha256 0257bedca70725e2813d37ec0834126e92b78ad0feaa6f42bbad8d21c6b197d2)
BibTeX
@misc{dc52ec450c2ebf,
  title = {Patient Survival and Its Relation to Tumor Absorbed Dose in [177Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors — Europe PMC PMID:42562609},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42562609},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_52ec450c2ebf; sha256 0257bedca70725e2813d37ec0834126e92b78ad0feaa6f42bbad8d21c6b197d2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42562609. Agents can read the archived copy with the MCP tool read_document.